Myotonic Dystrophy.
Hamel JI.
Continuum (Minneap Minn). 2022 Dec 1;28(6):1715-1734. doi: 10.1212/CON.0000000000001184.
Myotonic dystrophy.
Thornton CA.
Neurol Clin. 2014 Aug;32(3):705-19, viii. doi: 10.1016/j.ncl.2014.04.011. Epub 2014 Jun 6.
Myotonic dystrophy type 2: the 2020 update.
Meola G.
Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec.
Myotonic dystrophy.
Jozefowicz RF, Griggs RC.
Neurol Clin. 1988 Aug;6(3):455-72.
Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics.
Timchenko L.
Int J Mol Sci. 2022 Oct 8;23(19):11954. doi: 10.3390/ijms231911954.
Myotonic dystrophy type 1 - a multiorgan disorder.
Ørstavik K, Solbakken G, Rasmussen M, Sanaker PS, Fossmo HL, Bryne E, Knutsen-Øy T, Elgsås T, Heiberg A.
Tidsskr Nor Laegeforen. 2024 Apr 16;144(5). doi: 10.4045/tidsskr.23.0687. Print 2024 Apr 23.
Myotonic dystrophy.
Morgenlander JC, Massey JM.
Semin Neurol. 1991 Sep;11(3):236-43. doi: 10.1055/s-2008-1041227.
Myotonic dystrophy: candidate small molecule therapeutics.
Konieczny P, Selma-Soriano E, Rapisarda AS, Fernandez-Costa JM, Perez-Alonso M, Artero R.
Drug Discov Today. 2017 Nov;22(11):1740-1748. doi: 10.1016/j.drudis.2017.07.011. Epub 2017 Aug 2.
Cardiac Pathology in Myotonic Dystrophy Type 1.
Mahadevan MS, Yadava RS, Mandal M.
Int J Mol Sci. 2021 Nov 2;22(21):11874. doi: 10.3390/ijms222111874.
Myotonic dystrophy: diagnosis, management and new therapies.
Turner C, Hilton-Jones D.
Curr Opin Neurol. 2014 Oct;27(5):599-606. doi: 10.1097/WCO.0000000000000128.
